Abstract. Human bullous pemphigoid (BP) is an immune-mediated blistering disease characterized by autoantibodies against BP antigens (230/ 1 80 kd), which are constitutive glycoproteins of hemidesmosomes found in basal keratinocytes. Blistering diseases similar to human BP have been reported in dogs. IgG deposits at the basement membrane zone (BMZ) are a common feature of canine BP. Although circulating anti-BMZ IgG autoantibodies have been demonstrated in some cases of canine BP, the specific skin protein targeted by these autoantibodies has not been identified. In this study, we characterized the antigenic target of the autoantibodies in the serum from a 3-year-old castrated male Pit Bull Terrier with BP. Direct immunofluorescence of the patient's skin demonstrated IgG deposits at the dermal-epidermal junction. Indirect immunofluorescence demonstrated autoantibodies in the patient's serum that stained the epidermal roof of salt-split canine skin and left the dermal floor unstained. These serum autoantibodies did not stain normal intact dog skin but labeled intact bovine tongue. Direct immunoelectron microscopy of the dog's skin revealed IgG deposits within the hemidesmosomes of the basal keratinocytes. Western immunoblotting experiments showed that canine keratinocytes express both the 230-kd and 180-kd bullous pemphigoid antigens, and the autoantibodies from the patient's serum recognized the 180-kd bullous pemphigoid antigen in proteins extracted from canine and human keratinocytes. Canine BP has many parallel features with human BP including similar immune deposition of IgG within hemidesmosomes and a hemidesmosome-associated 180-kd glycoprotein target for circulating autoantibodies.
Human bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease. Clinically, human BP is characterized by tense blisters on inflamed or even urticarial-like skin. The tense bullae are due to a separation between the epidermis and dermis through the basement membrane zone (BMZ). Specifically, the cleavage plane of the human BP blister is through the lamina lucida of the BMZ.I5 In humans, autoantibodies in the skin and serum of BP patients are directed against two constitutive glycoproteins associated with the hemidesmosome of basal keratinocyte~.~~ These constitutive proteins are called bullous pemphigoid antigen 1 (BPAg1) and bullous pemphigoid antigen 2 (BPAg2), which are 230,000 and 180,000 daltons, respectively.
The first canine case of a blistering disease similar to human BP was described in 1978." Since this first report, a number of cases have been published, and the authors have emphasized that canine BP is the counterpart of human BP.7-9, 24, 2G28 The clinical features of this canine BP-like disease include erosions and ulcers of the oral mucosa and ulcers and pustules of the hair-bearing skin over the groin and axilla. 26 Frank intact blisters are not often seen because of the thinness of canine epidermis. The diagnosis of canine BP is currently based on these clinical features and histopathologic and immunofluorescence findings. 23 Nevertheless, less than 20% of canine BP patients have circulating antibodies against the BMZ as detected by indirect immunofluorescence (IIF).26 Moreover, it is not known whether dogs affected by this BP-like disease have autoantibodies to antigens similar to those of human beings with BP. Therefore, it is not clear that canine BP is the identical counterpart to human BP. In this study, we characterized a canine BP antigen by immunofluorescence, immunoelectron microscopy, and western immunoblotting and compared it with the BP antigens in humans.
Materials and Methods

Case report
A 3-year-old castrated male Pit Bull Terrier had a 2-year history of a recurrent vesicobullous dermatitis. There was no history of drug administration prior to the acute onset of blistering skin lesions. Most lesions evolved from erythematous macules and developed into vesicles. The bullae ruptured easily leaving erosions that appeared to heal normally. Lesions initially appeared on the prepuce, then new lesions developed on the face (lips, ears), feet, and trunk. Intact, individual or grouped, flaccid or tense, serous to hemorrhagic vesicles were observed on the inner side of the pinnae (Fig.  1) . Vesicles often developed at the site of scars from previous lesions. A linear, nonblistering erythematous band was symmetrically present on the maxillar gingivae. The dog appeared otherwise healthy. Microscopically, all sections were characterized by subepidermal splitting with an intact epidermis remaining at the roof of the vesicle (Fig. 2) . Early lesions had subepidermal vacuolation and clefting. Eosinophils and neutrophils were distributed along the base of the blister cleavage. Fully developed lesions consisted of serous to hemorrhagic subepidermal vesicles with a moderate to intense dermal infiltrate consisting of neutrophils, eosinophils, mast cells, and mononuclear cells.
Direct and indirect immunofluorescence
Direct immunofluorescence (DIF) was performed on perilesional skin, as previously described. 22 The fluorescent conjugates used included fluorescein isothiocyanate (FITC)-conjugated anti-dog IgG (Kirkegaard & Perry Laboratories, Gaithersburg, MD), anti-dog IgM (Bethyl Laboratories, Montgomery, TX), anti-dog IgA (Bethyl Laboratories), and anti-dog C3 (The Binding Site, San Diego, CA).
The IIF studies were performed as previously described.2 Samples of normal canine and human intact skin and normal canine and human salt-split skin36 were embedded in OCT against the human 180-kd BP antigen" for 60 minutes at room temperature. Washed sections were then incubated with FTTC-conjugated goat anti-dog IgG (gamma chain specific, Kirkegaard & Perry Laboratories), goat anti-human IgG (Cappel, Durham, NC), or goat anti-rabbit IgG (Cappel) for 20 minutes at room temperature. The sections were again washed in phosphate-buffered saline (PBS) and examined under the fluorescence microscope (Carl Zeiss, Thornwood, NY). Normal dog and human sera were used as negative controls.
Direct immunoelectron microscopy
Direct immunoelectron microscopy on the patient's perilesional skin was performed according to a previously described method.z5 Fourteen-micrometer cryosections were made from a biopsy of the patient's skin and fixed in 4.5% buffered formaldehyde for 1 hour at 4 C. Slices were incubated with horseradish peroxidase (HRP)-labeled anti-dog IgG (1 : 10, gamma chain specific, Kirkegaard & Perry Laboratories) for 4 hours at room temperature and 18 hours at 4 C. The HRP reaction was developed with chloronaphthol and postfixed with 2% osmium tetroxide for 4 hours. Samples were then embedded, and ultrathin sections were made and observed under an HUI 2A electron microscope (Hitachi, Tokyo, Japan).
compound IN). Five-micrometer
Cell culture and protein preparation of the cellular tions were obtained and air dried for 30 minutes. Bovine tongue'6 was similarly prepared, except the sections were fixed for 5 minutes in -20 C acetone before air drying. Sections were first incubated with serum from the canine patient and a human BP patient or with a rabbit antiserum (J- 17) extracts Normal canine keratinocyte cultures were established from biopsy specimens of a healthy young dog skin as previously described.1"32.34 Cells were collected after trypsinization with 0.25% trypsin ethylenediaminetetraacetic acid [EDTA] buffer and plated on collagen-coated dishes. Primary cultures were subcultured into William's medium E (GIBCO Laboratories, Grand Island, NY) containing 10% Nu-serum IV (Collaborative Research, Bedford, MA) and supplemented with 5 ng/ml of epidermal growth factor (Sigma Chemical Co., St. Louis, MO) and M cholera toxin (ICN Biomedicals, Irvine, CA).30 Cultures were passaged twice to remove any contaminating fibroblasts and melanocytes. Human keratinocyte cultures were initiated from newborn foreskin keratinocytes in KGM (Clonetics, San Diego, CA) as described previously. l 2 The proteins extracted from canine and human keratinocyte cultures were obtained from cultures passaged two or three times. Cultures were washed twice with cold PBS, lysed by phosphate buffer containing 2% sodium dodecyle sulfate (SDS), 5 mM EDTA, 50 pM N-methylmaleilide, and 50 pM phenylmethylsulfonylfloride, and scraped off the petri dishes with a plastic policeman. The mixture was then vortexed for 30 seconds and sonicated for 20 seconds. The samples were centrifuged at 16,000 x g for 30 minutes and stored at -70 C until used in western immunoblotting.
Salt-split skin and extraction of dermal component
Normal canine nose skin (2 cmz) was cut into small pieces after removing the subcutaneous tissue and incubated in 1 M NaCl for 72 hours. For extraction of the dermal proteins, the epidermis was first removed from the salt-split skin, and the dermal proteins were solubilized with 6 M guanidine hydrochloride (Sigma) supplemented with protease inhibit o r~.~~ Guanidine-extracted proteins were centrifuged at 16,000 x gfor 30 minutes, and supernatants were extensively dialyzed against cold
The samples were then lyophilized and resuspended at a concentration of 3 mg/ml in phosphate buffer containing 2% SDS with 30 mg/ml of dithiothreitol.
Western immunoblotting
Proteins extracted from cell culture or tissues were separated by 6% SDS-polyacrylamide gel electrophoresis18 and electrophoretically transfered to a nitrocellulose membrane.31
The membrane was incubated with serum from a dog with BP, serum from a human with BP, or a rabbit antiserum (J-17) against the human 180-kd BP antigen." After extensive washing, the membranes were incubated with HRP-conjugated goat anti-dog IgG (gamma chain specific, Kirkegaard & Perry Laboratories), goat anti-human IgG (Cappel), or goat anti-rabbit IgG (Cappel), respectively. Visualization of the bound HRP-conjugated antibodies was detected by developing the reaction with chloronaphthol (Bio-Rad Laboratories, Hercules, CA). Six normal dog sera were used as negative controls.
Results
Immunofluorescence microscopy
The DIF studies of the patient's skin revealed a linear deposition of IgG (Fig. 3) , IgM, and C3 (data not shown) at the dermal-epidermal junction. The IIF reaction of the patient's serum with normal intact canine skin and monkey esophagus were negative (data not shown). IIF of the patient's serum with normal canine salt-split skin showed immunolabeling of the epidermal side of the salt-split skin (Fig. 4) . There was no fluorescent labeling of the dermal side. IIF of the patient's serum with intact bovine tongue showed strong labeling of the dermakpidermal junction at a dilution of 1 : 20 (Fig. 5) . Similar results were obtained with either canine BP serum or human BP serum. The IIF results are summarized in Table 1 . Normal dog and human sera did not label the BMZ of any of the substrates tested (data not shown). 
Electron microscopy
Electron microscopic examination of lesional skin showed areas where the skin was intact with a wellformed BMZ consisting of the keratinocyte plasma membrane and hemidesmosomes apposed to a lamina lucida and underlying lamina densa. In areas of the blister cleavage plane, there was a clear separation through the lamina lucida region of the BMZ. This separation placed the keratinocyte plasma membrane and hemidesmosomes with the epidermal roof of the separation, and the lamina densa formed the dermal floor of the separation (Fig. 6) .
Direct immunoelectron microscopic examination of lesional slun revealed IgG deposits within the hemidesmosomes of the basal keratinocytes (Fig. 7) . No immune deposits were seen within the lamina lucida, lamina densa, or sublamina densa regions of the BMZ.
Western immunoblot
To identify the skin protein targeted by the circulating autoantibodies in the serum of the patient, western immunoblots were performed using proteins extracted from cultured normal canine and human keratinocytes and canine dermis. Positive control an- tibodies were a human BP serum known to recognize the 230-kd human BPAg and 5-17, a polyclonal antibody to the 180-kd BP antigen that was produced by immunizing a rabbit with a fusion protein synthesized from the gene coding for the noncollagenous cytoplasmic N-terminus domain of the 180-kd BP antigen." The human control BP serum labeled a 230-kd protein band in the extract from canine keratinocytes, and the canine BP patient's serum contained an autoantibody that labeled a 180-kd band (Fig. 8) . This band comigrated with a 180-kd band labeled by the J-17 antibody (Fig. 8) .
As expected, the human BP serum labeled the 230-kd BPAgl and the 5-17 antiserum labeled the 180-kd BPAg2 in the extract of proteins from human keratinocyte cultures (data not shown). The canine BP patient's serum also labeled a 180-kd protein in the human keratinocyte extract but did not recognize the 230-kd BP antigen (data not shown). The electrophoretical migration of the 180-kd band was identical to that of the band labeled by the 5-17 antiserum. The fact that the patient's serum labeled a 180-kd band that comigrates with the 180-kd BPAg2 band identified by the J-17 antiserum suggests that the canine BP serum contains an autoantibody that recognizes the 180-kd BPAg2. The proteins extracted from canine dermis were not labeled with any of the canine or human BP sera or with the 5-17 antiserum (data not shown). studied by immunocytochemistry of cultured mucosal keratin~cytes,~~ corneal epitheli~m,~ and skin.5 Similarity of expression and gene composition of the 230-kd BPAgl between humans and dogs has been evaluated by immunofluorescence and Southern blotting, respectively.' These reports suggested that the BP antigen expressed by canine keratinocytes is related to the human gene encoding for the human 230-kd BP antigen. A recent study showed that canine keratinocytes express the 230-kd BP antigen, as detected with a human BP serum by western immunoblotting.I3 In the present study, we also demonstrated by western immunoblotting using a human BP serum that proteins extracted from canine keratinocytes contained the 230-kd (BPAgl) and the 180-kd (BPAg2) BP antigens. The 180-kd BP antigen was labeled when keratinocyte extracts from both species were incubated with canine BP serum.
According to the literature, the 180-kd BP antigen is a transmembrane protein with both noncollagenous and collagenous domains," whereas the 230-kd BP antigen is a noncollagenous intracellular protein. 32 Autoantibodies to the 180-kd BP antigen have been detected in some human patients with BP and herpes gestations, a human blistering disease associated with pregnancy. 32 The frequencies of different BP antigens detected by autoantibodies from human BP patients are variable. In one study, 42.9% (12/28) of sera from human BP patients labeled the 230-kd BP antigen, whereas 28.6% (8/28) labeled the 180-kd BP antigen. 4 In another study, 25.3% (19/75) of human BP sera reacted only with the 180-kd BP antigen.'O In the present study of canine BP serum, only the 180-kd was targeted by the patient's autoantibodies. Although canine keratinocytes express the 230-kd BP antigen, it still remains to be determined whether or not any canine BP patients have autoantibodies against the 230-kd BP antigen.
In human BP, 70% of the patients have anti-BMZ antibodies in their blood as detected by IIF. I 9 Salt-split skin has been the most useful substrate for IIF in human bullous diseases because it is more sensitive than intact skin substrate.6 It also allows researchers to rule out bullous systemic lupus erythematosus and epidermolysis bullosa acquisita, diseases that may mimic BP, because autoantibodies in these two diseases bind to the type VII collagen (anchoring fibrils) on the dermal side of the salt-split skin. The results here suggest that salt-split canine skin may be more sensitive than intact skin when used for IIF detection of BP autoantibodies in canine serum. Bovine tongue substrate may also be used for the IIF study, because BP antigen appears to be more abundant in bovine tongue BMZ.l6 However, the location of the autoantigen cannot be determined when intact bovine tongue is used.
Although we have shown that canine keratinocytes express a 180-kd protein recognized by a rabbit antiserum against the 180-kd human BP antigen and one canine BP serum, we have not demonstrated conclusively that human and canine BP antigens (BPAg2) are identical. Such a conclusion would require nucleotide sequencing of both genes or amino acid sequencing of both proteins. The human and mouse genes encoding BPAg2 have been cloned and sequenced; they are approximately 90%
Thus, it would be reasonable to expect approximately the same degree of homology between human and canine BPAg2. Although we have not shown conclusive evidence for the identity between the canine and human 180 kd BP antigen, these data do suggest that they contain similar antibody recognition sites.
